A look at Intellia Therapeutics, Inc. and Editas Medicine, Inc., including their restructuring and pipeline prioritization.

Here’s what you can do to help boost your brain’s neurogenesis.

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

In this valuable study, Roiuk et al employed a combination of ribosome profiling and reporter assays to provide convincing evidence that eIF2A is not involved in translational regulation in cultured ...

Genetic changes are a significant cause of infertility, impacting over 15% of the global population. TLE6, a major protein ...

Infertility is a major global challenge associated with physiological and psychological impact. Genetic mutations that affect ...

CRISPR screening libraries are collections of carefully designed single-guide RNAs (sgRNAs) that allow researchers to ...

The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...

Gene editing involves precise changes in DNA sequences using enzymes, revolutionizing medical, agricultural, and research ...

CRISPR-Cas9 pioneer presented with National Medal of Technology and Innovation in White House awards ceremony China-born ...

popularly called knockout or banger, inside the church on New Year’s Eve. PUNCH Metro gathered that the event left the boy, identified simply as Joseph, dead and others injured. A source who ...